AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2019

Apr 1, 2019

32724_dirs_2019-04-01_de7db0a6-cf47-494b-8256-84616341e05f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-03-28

Reporting Person: Deschamps Philippe (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-28	Employee Stock Option (Right to Buy)	$6.76	A	160000	Acquired	2029-03-28	Class A Common Stock (160000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of forty-eight (48) successive equal monthly installments measured from March 28, 2019, subject to the Reporting Person's continued service through each applicable vesting date.